BAFF as a predictive marker for treatment response in immune thrombocytopenia patients
The Egyptian Journal of Haematology · 2023-10 · 48 (4) · 316-322
DOI: 10.4103/ejh.ejh_53_23 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Egyptian Journal of Haematology, online erschienen am 08.02.2024. Verfasst von Mona Ashraf Al-dosoky Hamza und 3 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
Background Immune thrombocytopenic purpura (ITP) is a hematological autoimmune bleeding disorder that characterized by isolated thrombocytopenia (platelet count
Zitieren
APA
Hamza, M. A. A., Elbedewy, T. A. E., El-Kholy, R. A., & Sheira, G. M. (2023). BAFF as a predictive marker for treatment response in immune thrombocytopenia patients. The Egyptian Journal of Haematology, 48(4), 316-322. https://doi.org/10.4103/ejh.ejh_53_23
Vancouver
Hamza MAA, Elbedewy TAE, El-Kholy RA, Sheira GM. BAFF as a predictive marker for treatment response in immune thrombocytopenia patients. The Egyptian Journal of Haematology. 2023;48(4):316-322. doi:10.4103/ejh.ejh_53_23
BibTeX
@article{Hamza2023,
author = {Hamza, Mona Ashraf Al-dosoky and Elbedewy, Tamer Abd Elhamid and El-Kholy, Rasha Adel and Sheira, Gehan Mohamed},
title = {BAFF as a predictive marker for treatment response in immune thrombocytopenia patients},
journal = {The Egyptian Journal of Haematology},
year = {2023},
volume = {48},
number = {4},
pages = {316--322},
doi = {10.4103/ejh.ejh_53_23}
}
EUVIMED